[1] HUANG Y. IDF Diabetes Atlas 8th Edition. International Diabetes Federation, 2017; 41.
[2] XU Y, WANG L, HE J, et al. Prevalence and control of diabetes in Chinese adults. JAMA, 2013; 310, 948−59. doi:  10.1001/jama.2013.168118
[3] GOLDBERG RB, KENDALL DM, DEEG MA, et al. A comparison of lipid and glycemic effects of pioglitazone and rosiglitazone in patients with type 2 diabetes and dyslipidemia. Diabetes Care, 2005; 28, 1547−54. doi:  10.2337/diacare.28.7.1547
[4] KRAUSS R M, SIRI P W. Dyslipidemia in type 2 diabetes. Med Clin North Am, 2004; 88, 897−909. doi:  10.1016/j.mcna.2004.04.004
[5] ZHANG L, QIAO Q, TUOMILEHTO J, et al. Blood lipid levels in relation to glucose status in European men and women without a prior history of diabetes: the DECODE Study. Diabetes Res Clin Pract, 2008; 82, 364−77. doi:  10.1016/j.diabres.2008.08.022
[6] YANG W, LU J, WENG J, et al. Prevalence of diabetes among men and women in China. N Engl J Med, 2010; 362, 1090−101. doi:  10.1056/NEJMoa0908292
[7] TIROSH A, SHAI I, BITZUR R, et al. Changes in triglyceride levels over time and risk of type 2 diabetes in young men. Diabetes Care, 2008; 31, 2032−7. doi:  10.2337/dc08-0825
[8] PERRY IJ, WANNAMETHEE SG, WALKER MK, et al. Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men. BMJ, 1995; 310, 560−4. doi:  10.1136/bmj.310.6979.560
[9] CHRISTIAN JB, BOURGEOIS N, SNIPES R, et al. Prevalence of severe (500 to 2,000 mg/dl) hypertriglyceridemia in United States adults. Am J Cardiol, 2011; 107, 891−7. doi:  10.1016/j.amjcard.2010.11.008
[10] RHEE EJ, HAN K, KO SH, et al. Increased risk for diabetes development in subjects with large variation in total cholesterol levels in 2,827,950 Koreans: A nationwide population-based study. PLoS One, 2017; 12, e176615.
[11] SEO MH, BAE JC, PARK SE, et al. Association of lipid and lipoprotein profiles with future development of type 2 diabetes in nondiabetic Korean subjects: a 4-year retrospective, longitudinal study. J Clin Endocrinol Metab, 2011; 96, E2050−4. doi:  10.1210/jc.2011-1857
[12] CUI J, SUN J, WANG W, et al. The association of triglycerides and total cholesterol concentrations with newly diagnosed diabetes in adults in China. Oncotarget, 2017; 8, 103477−85.
[13] ALMAJWAL AM, AL-BAGHLI NA, BATTERHAM MJ, et al. Performance of body mass index in predicting diabetes and hypertension in the Eastern Province of Saudi Arabia. Ann Saudi Med, 2009; 29, 437−45. doi:  10.4103/0256-4947.57165
[14] XIAO X, LIU Y, SUN C, et al. Evaluation of different obesity indices as predictors of type 2 diabetes mellitus in a Chinese population. J Diabetes, 2015; 7, 386−92. doi:  10.1111/1753-0407.12201
[15] DOTEVALL A, JOHANSSON S, WILHELMSEN L, et al. Increased levels of triglycerides, BMI and blood pressure and low physical activity increase the risk of diabetes in Swedish women. A prospective 18-year follow-up of the BEDA study. Diabet Med, 2004; 615−22.
[16] MCPHILLIPS JB, BARRETT-CONNOR E, WINGARD DL. Cardiovascular disease risk factors prior to the diagnosis of impaired glucose tolerance and non-insulin-dependent diabetes mellitus in a community of older adults. Am J Epidemiol, 1990; 131, 443−53. doi:  10.1093/oxfordjournals.aje.a115519
[17] KANAYA AM, WASSEL FC, de REKENEIRE N, et al. Predicting the development of diabetes in older adults: the derivation and validation of a prediction rule. Diabetes Care, 2005; 28, 404−8. doi:  10.2337/diacare.28.2.404
[18] HADAEGH F, HATAMI M, TOHIDI M, et al. Lipid ratios and appropriate cut off values for prediction of diabetes: a cohort of Iranian men and women. Lipids Health Dis, 2010; 9, 85. doi:  10.1186/1476-511X-9-85
[19] HE S, WANG S, CHEN X, et al. Higher ratio of triglyceride to high-density lipoprotein cholesterol may predispose to diabetes mellitus: 15-year prospective study in a general population. Metabolism, 2012; 61, 30−6. doi:  10.1016/j.metabol.2011.05.007
[20] KOMPOTI M, MARIOLIS A, ALEVIZOS A, et al. Elevated serum triglycerides is the strongest single indicator for the presence of metabolic syndrome in patients with type 2 diabetes. Cardiovasc Diabetol, 2006; 5, 21. doi:  10.1186/1475-2840-5-21
[21] QIAO Q, PANG Z, GAO W, et al. A large-scale diabetes prevention program in real-life settings in Qingdao of China (2006-2012). Prim Care Diabetes, 2010; 4, 99−103. doi:  10.1016/j.pcd.2010.04.003
[22] Institute Of Cellular Medicine. Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia. Geneva World Health Organization, 2006.
[23] Joint Committee For Developing Adults. Guidelines on prevention and treatment of blood lipid abnormality in Chinese adults (Revised in 2016). Chinese Circulation Journal, 2016; 31, 937−53.
[24] GAO WG, DONG YH, PANG ZC, et al. Increasing trend in the prevalence of Type 2 diabetes and pre-diabetes in the Chinese rural and urban population in Qingdao, China. Diabet Med, 2009; 26, 1220−7. doi:  10.1111/j.1464-5491.2009.02832.x
[25] SWETS JA. Measuring the accuracy of diagnostic systems. Science, 1988; 240, 1285−93. doi:  10.1126/science.3287615
[26] WANG YL, KOH WP, TALAEI M, et al. Association between the ratio of triglyceride to high-density lipoprotein cholesterol and incident type 2 diabetes in Singapore Chinese men and women. J Diabetes, 2017; 9, 689−98. doi:  10.1111/1753-0407.12477
[27] ALBERTI KG, ECKEL RH, GRUNDY SM, et al. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation, 2009; 120, 1640−5. doi:  10.1161/CIRCULATIONAHA.109.192644
[28] UNGER RH, ZHOU YT. Lipotoxicity of beta-cells in obesity and in other causes of fatty acid spillover. Diabetes, 2001; 50(Suppl 1), S118−21.
[29] LI N, FU J, KOONEN DP, et al. Are hypertriglyceridemia and low HDL causal factors in the development of insulin resistance? Atherosclerosis, 2014; 233, 130−8. doi:  10.1016/j.atherosclerosis.2013.12.013
[30] ONAT A, CAN G. Enhanced proinflammatory state and autoimmune activation: a breakthrough to understanding chronic diseases. Curr Pharm Des, 2014; 20, 575−84. doi:  10.2174/138161282004140213145551
[31] ARAZ AM. Sleep Disorders and Attention Deficit: A Consequence of Proinflammatory State? J Clin Sleep Med, 2018; 14, 1081. doi:  10.5664/jcsm.7190
[32] QI Q, LIANG L, DORIA A, et al. Genetic predisposition to dyslipidemia and type 2 diabetes risk in two prospective cohorts. Diabetes, 2012; 61, 745−52. doi:  10.2337/db11-1254